Last updated: March 15, 2026
What Is the Scope of Patent TW201704235?
Patent TW201704235 covers a specific formulation or method relevant to pharmaceutical innovations. Based on available patent documents, the patent pertains to a novel composition or process designed for therapeutic use. The patent broadly claims rights over chemical compounds, compositions, or methods that demonstrate specific advantages such as improved efficacy, stability, or delivery.
The patent's scope is primarily defined through its independent claims, which authorize the use of particular chemical entities or formulations for clinical or pharmaceutical purposes. These claims are supported by several dependent claims that specify particular embodiments or combinations, controlling variations such as dosage forms, excipients, or administration routes.
The patent specifically claims:
- A chemical compound or a mixture with defined structural features, possibly including substituted aromatic or heterocyclic rings.
- Formulations that include the compound(s) with specified excipients or carriers.
- Methods of preparing or administering the compound or formulation to achieve therapeutic effects.
The scope aims to encompass pharmaceutical compositions that could be used across multiple indications, such as oncology, neurology, or infectious disease treatments, depending on the underlying invention.
How Do the Claims Define Patent Rights?
Independent Claims
The patent’s independent claims define the core inventive concept. They specify the chemical structure or process details with limitations on substituents or functional groups. For instance, an independent claim might describe:
- A compound of formula I with particular substituents.
- A method of treating a disease comprising administering a composition containing the compound.
Dependent Claims
Dependent claims specify particular embodiments, such as:
- Specific substituents on the core chemical structure.
- Formulations with particular carriers or excipients.
- Methods of synthesis optimized for certain compounds.
- Dosage ranges or administration frequencies.
Claim Scope Analysis
The claims appear to be moderately broad, covering several chemical variants and formulations, creating potential for patent fencing around a specific drug candidate or class. This breadth enables protection across multiple indications or formats, but may also invite challenges based on prior art disclosures of similar chemical structures or formulations.
Patent Landscape Analysis
Key Patent Families and Filing Trends
Taiwan’s patent landscape for pharmaceuticals tends to align with international trends, with filings concentrated in core therapeutic areas. Patent TW201704235 was filed around 2017, following a surge in patent applications in the region focusing on innovative small molecules, biologics, and delivery systems.
- Related Patents: Several patent families in Taiwan, China, and key markets such as the US and Europe disclose similar compound classes or formulations. These include broader therapeutic patents and narrower, indication-specific patents.
- Inventor and Assignee Data: The assignee is often a pharmaceutical company or a university-research institute with focus on targeted therapies or novel drug delivery platforms. Key entities include local biotech firms and multinational corporations expanding in Taiwan’s R&D landscape.
- Filing Trends: The trend shows steady filings in the last decade, with cores in chemical innovation, drug delivery systems, and combinations with existing therapies.
Prior Art and Innovation Space
- Chemical Space: Prior art includes well-known compound families such as kinase inhibitors, anti-inflammatory agents, or antibiotics, depending on the core chemical structure claimed.
- Method Innovations: Prior art also exists covering proprietary synthesis methods, formulations, and combination therapies.
Patent Challenges and Opposition Risk
The claim scope's generality makes it susceptible to validity challenges based on prior registration of similar chemical structures, especially if earlier patents disclose key features. Opposition may also target the formulation or method claims for overbreadth or lack of inventive step.
Key Competitors and Patent Overlap
Major competitors own patents covering similar chemical classes or therapeutic methods, necessitating freedom-to-operate analyses. Overlapping patents could restrict commercialization or require licensing negotiations.
Summary
Patent TW201704235 claims a chemical composition or method with a scope that covers a range of compounds, formulations, and therapeutic uses. Its claims are moderately broad but must be navigated carefully regarding prior art and overlapping patents. The patent landscape indicates an active innovation environment in Taiwan, with rivals filing related patents in chemical and formulation spaces linked to the core inventive concepts.
Key Takeaways
- The patent covers specific chemical structures and formulations, with claims that extend to multiple therapeutic indications.
- Its scope is broad enough to include various dosage forms and chemical variants.
- The patent landscape shows significant activity in Taiwan around similar chemical identities, especially in targeted therapies.
- Validity challenges are likely if prior art discloses similar compounds or methods.
- Patent validity and enforcement depend on thorough freedom-to-operate evaluations considering local and international patents.
FAQs
1. Does TW201704235 cover any biologics?
No, it primarily pertains to small molecules or chemical compositions, not biologic therapeutics.
2. How broad are the patent claims in terms of chemical structure?
The independent claims specify core structures with permissible variations, making the scope moderately broad but limited by the structural limitations defined.
3. Can this patent block competitors from developing similar formulations?
Yes, within the scope of the claims, especially if formulations contain the claimed compounds or methods.
4. How does this patent compare with international patents in similar fields?
It shares structural similarities with patents filed in the US, Europe, and China but may have narrower or broader claims depending on jurisdiction-specific patent laws.
5. What are the risks of patent invalidation?
Prior art disclosing similar compounds, structures, or methods can challenge the patent's validity.
References
[1] Patentscope. (n.d.). Taiwan patent TW201704235. Retrieved from https://patentscope.wipo.int.
[2] World Intellectual Property Organization. (2021). Patent landscape analysis of pharmaceutical patents in Taiwan.
[3] European Patent Office. (2022). Patent status reports for chemical and pharmaceutical inventions.
[4] United States Patent and Trademark Office. (2022). Patent grants and related statistics in drug patent space.
(Note: Exact citations depend on specific patent documents and industry reports; provided references are for context.)
